dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Vonk, Madelon |
dc.contributor.author | Guillen Del Castillo, Alfredo |
dc.contributor.author | Kreuter, Michael |
dc.contributor.author | Avis, Mandy |
dc.contributor.author | Marzin, Kristell |
dc.contributor.author | Mack, Salome R. |
dc.date.accessioned | 2022-07-19T08:36:16Z |
dc.date.available | 2022-07-19T08:36:16Z |
dc.date.issued | 2022-01 |
dc.identifier.citation | Vonk MC, Guillén-Del-Castillo A, Kreuter M, Avis M, Marzin K, Mack SR, et al. A Drug–Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease. Eur J Drug Metab Pharmacokinet. 2022 Jan;47:81–9. |
dc.identifier.issn | 1432-1459 |
dc.identifier.uri | https://hdl.handle.net/11351/7807 |
dc.description | Nintedanib; Interaccions farmacològiques; Esclerosi sistèmica |
dc.language.iso | eng |
dc.publisher | Springer |
dc.relation.ispartofseries | European Journal of Drug Metabolism and Pharmacokinetics;47 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pulmons - Malalties - Complicacions |
dc.subject | Farmacocinètica |
dc.subject | Esclerosi sistemàtica progressiva |
dc.subject.mesh | Scleroderma, Systemic |
dc.title | A Drug–Drug Interaction Study to Investigate the Effect of Nintedanib on the Pharmacokinetics of Microgynon (Ethinylestradiol and Levonorgestrel) in Female Patients with Systemic Sclerosis-Associated Interstitial Lung Disease |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1007/s13318-021-00728-7 |
dc.subject.decs | esclerodermia sistémica |
dc.relation.publishversion | https://doi.org/10.1007/s13318-021-00728-7 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Vonk MC] Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands. [Guillén-Del-Castillo A] Unitat de Malalties Autoimmunes Sistèmiques, Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Kreuter M] Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany. [Avis M] Boehringer Ingelheim B.V., Alkmaar, The Netherlands. [Marzin K, Mack SR] Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany |
dc.identifier.pmid | 34664183 |
dc.identifier.wos | 000705679500001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |